Cordyceps militaris Induces Immunogenic Cell Death and Enhances Antitumor Immunogenic Response in Breast Cancer

Abstract EN

Cordyceps militaris has been widely used as a traditional medicine in East Asia.

Its effects against breast cancer have been reported previously.

However, whether C.

militaris-induced breast cancer cell death is immunogenic remains unelucidated.

This study aimed to determine whether ethanolic extracts of C.

militaris (CM-EE) could induce immunogenic cell death (ICD) in breast cancer immunotherapy to improve the efficacy of immune checkpoint inhibitors.

Human and mouse breast cancer cells were treated with various concentrations of CM-EE for 72 h, and cytotoxicity was measured using the sulforhodamine B assay.

Flow cytometry was used to assess cell death with annexin V/7-AAD staining and measure the surface exposure of damage-associated molecular pattern (DAMP) molecules including calreticulin, HSP70, and HSP90.

Western blot for cleaved poly (ADP-ribose) polymerase (PARP) was used to confirm apoptotic cell death.

The immunogenicity of CM-EE-induced dead cells was evaluated using the CFSE dilution assay.

CM-EE reduced the viability of human (MCF7, MDA-MB-231, HS578T, and SKBR3) and mouse (4T1-neu-HA, TUBO-HA, and TUBO-P2J-HA) breast cancer cells.

The IC50 was 25–50 µg/ml in human breast cancer cells and 10–50 µg/ml in mouse breast cancer cells at 72 h.

CM-EE-treated breast cancer cells were positively stained by annexin V, cleaved PARP, and cleaved caspase 3/7 which were increased upon CM-EE treatment.

Surface exposure of DAMP molecules was increased in dose- and time-dependent manners.

The CFSE dilution assay revealed that dendritic cells fed with CM-EE-treated breast cancer cells successfully stimulated tumor-specific T cell proliferation without inhibiting DC function and T cell proliferation.

The expression of PD-L1 mRNA and protein level was increased in dose-dependent manners.

In addition, CM-EE also potentiated the cytotoxic activity of tumor-specific T cells.

CM-EE can induce immunogenic and apoptotic cell death in breast cancer cells, and it is a good candidate for cancer immunotherapy and may improve the efficacy of immune checkpoint inhibitors.